Dr. Hammers on Combinations of IDO and PD-1 Inhibitors in RCC

How I Use PD-1 Inhibitors in RCCПодробнее

Dr. Hammers on Combination of Vaccines and Immune Checkpoint Inhibitors in RCCПодробнее

Dr. Hammers Discusses Combining IDO and PD-1 Inhibitors in RCCПодробнее

Dr. Luke Discusses the Combination of PD-1 and IDO Inhibitors in MelanomaПодробнее

Dr. Luke Discusses PD-1 Plus IDO Inhibitors in MelanomaПодробнее

Dr. Hammers on Combination Strategies in Kidney CancerПодробнее

Dr. Hammers Discusses Immunotherapy in RCCПодробнее

PD-1 Combinations Explored in RCCПодробнее

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCCПодробнее

Dr. McDermott on VEGF/PD-1 Inhibition in RCCПодробнее

Dr. Hammers on Study of HyperAcute Renal Immunotherapy in RCCПодробнее

A Novel Approach: TKI/I-O Combinations in RCCПодробнее

Dr. McGregor on Combination Therapies With Nivolumab, Cabozantinib, and Sunitinib in RCCПодробнее

Dr. McDermott on TKI/Immunotherapy Combinations in RCCПодробнее

Immunotherapy Combination Strategies in RCCПодробнее

Potential Immunotherapy Combinations in RCCПодробнее

Future Treatment Options for Patients With RCCПодробнее

Dr. Hammers on Next Steps with Immunotherapy in RCCПодробнее

IKCS 2020: Session 5: Multimodality Therapy For Metastatic RCCПодробнее